[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hypoglycemia-diabetic\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hypoglycemia-diabetic":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,67],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100600210","personalized-hypoglycemia-outpatient-treatment---a-feasibility-study-100600210",false,"NCT07094529","Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study","The Feasibility of Personalized Hypoglycemia Outpatient Treatment for People Living With Type 2 Diabetes Mellitus","PHOT","Inclusion Criteria:\n\n* In order to be eligible to participate in this study, an individual must meet all of the following criteria:\n\n  1. Consent provided\n  2. Age \\>= 18 years.\n  3. Diagnosed as type 2 diabetes mellitus.\n  4. Type 2 diabetes medications include at least one of the following for at least one month prior to entering the study: sulfonylurea or insulin of any type.\n\nExclusion Criteria:\n\n* An individual who meets any of the following criteria will be excluded from participation in this study:\n\n  1. Diagnosed as another form of diabetes mellitus.\n  2. Has a history of hypoglycemia unawareness.\n  3. Had a hypoglycemia event, defined as capillary blood glucose \\\u003C 3.9 mmol\u002FL within 24 hours prior to the study visit booking time.","ALL","18 Years",{"count":20,"type":21},120,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol\u002FL), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time.\n\nThe two study interventions that the participant can choose to complete (one or both interventions).\n\nBased on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities, and choose one of 4 capillary blood glucose recheck times.",[27,28],"Type 2 Diabetes (T2DM)","Hypoglycemia (Diabetic)",[30],"hypoglycemia","RECRUITING","2025-07-23",{"date":34,"type":35},"2025-07-30","ACTUAL",{"date":37,"type":35},"2025-07-21",{"date":39,"type":21},"2027-06-30",{"name":41,"class":42},"Ottawa Hospital Research Institute","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":22,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100597253","comparing-blood-glucose-control-intraoperative-between-insulin-drip-vs-insulin-boluses-will-provide-valuable-information-on-the-optimal-method-for-achieving-blood-glucose-control-intraoperatively-100597253","NCT07056088","Comparing Blood Glucose Control Intraoperative Between Insulin Drip vs. Insulin Boluses Will Provide Valuable Information on the Optimal Method for Achieving Blood Glucose Control Intraoperatively.","A Randomized Controlled Trial Comparing Blood Glucose Control Intraoperative Between Insulin Drip vs. Insulin Boluses","RANDOM-IB","Inclusion Criteria:\n\n* All adult patients (above 18 y of age undergoing Cardiac surgery with preoperative blood glucose level (80 -180 mg\u002FdL)\n* Patient with History of diabetes and those taking antidiabetics medications.\n\nExclusion Criteria:\n\n* Patients with known allergy or insulin intolerance.\n* Patients with severe hepatic Dysfunction.\n* Patient with History of hypoglycemic events in the past 6 month prior to surgery.",{"count":53,"type":21},384,[24],"Cardiac surgery patients often experience elevated blood glucose levels, which can lead to poor surgical outcomes and increased postoperative complications. Therefore, tight blood glucose control during surgery is important. Currently, there is no consensus on the best method for blood glucose control during cardiac surgery. This proposal aims to perform a randomized controlled trial to compare blood glucose control intraoperatively using an insulin drip versus insulin boluses. The primary objective of the study is to compare blood glucose control intraoperatively between patients who receive insulin drip and patients who receive insulin boluses during adult cardiac surgery. This study will be a randomized controlled trial in which adult patients undergoing cardiac surgery will be randomized into two groups: insulin drip and insulin boluses. Patients with a history of diabetes or those currently taking antidiabetic medications will be included in the study. This randomized controlled trial will provide valuable information on the optimal method for achieving blood glucose control intraoperatively. The results of this study may help improve patient outcomes and reduce the incidence of postoperative complications.",[28],"NOT_YET_RECRUITING","2025-07-03",{"date":60,"type":35},"2025-07-09",{"date":62,"type":21},"2025-07",{"date":64,"type":21},"2029-08",{"name":66,"class":42},"King Faisal Specialist Hospital & Research Center",{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":78,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":102},"100552468","continuous-bloodsugar-monitoring-system-with-a-sensor-compared-to-fingerstick-bloodsugar-monitoring-100552468","NCT06473480","Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring","Continuous GLUCOse Monitoring System With a SENSor Compared to Fingerstick Glucose Monitoring in Surgical Wards (GLUCOSENS)","GLUCOSENS","Inclusion Criteria:\n\n* Hospitalized patients (≥ 18 years old) in surgical wards\n* Glucose measurements at least 4 times (OUH) and 3 times (SUH) daily for at least three days, prescribed by surgeon\n* Expected hospitalization for at least three days\n* Communicates in Danish\n* Signed a declaration of consent to study participation\n* At risk of hypo- and hyperglycemia (with or without a diabetes diagnosis)\n* Specific for substudy 4 inclusion criteria as above with the following add on: Patients being treated with insulin at discharge and patients residing within the OUH admission area.\n\nExclusion Criteria:\n\n* Cognitively impaired patients\n* Indication for glucose monitoring solely because of parenteral nutrition treatment\n* Patients admitted with a CGMS\n* Patients from the point-of-care fingerstick capillary glucose monitoring group cannot be included in the continuous glucose monitoring system group\n\nEligibility criteria solely for substudy 7\n\nInclusion Criteria:\n\n* Nursing staff with at least one month of experience with both point-of-care fingerstick capillary glucose monitoring and continuous glucose monitoring system and are registered nurses or certified nursing assistants","110 Years",{"count":77,"type":21},329,[24],"This clinical trial aims to compare a continuous glucose monitoring system with traditional fingerstick blood glucose monitoring. The study focuses on adult patients in general surgical wards who need regular blood glucose checks due to the risk of low or high blood sugar levels.\n\nThe goal is to learn if using a continuous glucose monitoring system is better than fingerstick monitoring in managing glucose levels, preventing complications, improving patient satisfaction and experience, reducing nursing staff workload, and improving nursing staff' experience. The study also compares the accuracy of glucose readings from the continuous glucose monitoring system with those from fingerstick tests and blood samples.\n\nThe hypothesis is that CGMS is accurate and effective for monitoring glucose levels in surgical patients. This could lead to better blood sugar control, fewer complications, shorter hospital stays, and improved experiences for both patients and nursing staff.",[81,28,82,83],"Diabetes Mellitus","Hypoglycemia Night","Hyperglycemia",[85,86,87,88,89,90,91,92],"Blood glucose monitoring","point-of-care fingerstick capillary glucose monitoring","continuous glucose monitoring system","Patient satisfaction","Patient experience","Nursing staff's workload","Nursing staff's experience","accuracy","2025-03-31",{"date":95,"type":35},"2025-04-03",{"date":97,"type":35},"2024-06-26",{"date":99,"type":21},"2025-12-31",{"name":101,"class":42},"Odense University Hospital",2]